HealthEdge Investment Partners, LLC, a healthcare-focused private equity fund, announced that it had completed an investment in Anodyne, LLC, the maker of footwear often prescribed for diabetic patients.
Anodyne was founded in 2015 by a group of industry executives to reimagine the diabetic footwear market by providing options with more style. The company also manufacturers a line of shoe inserts and custom orthotics at its in-house production facility in Milwaukee, WI.
HealthEdge Partner Scott Heberlein commented, “Diabetic foot complications represent a significant medical risk to the growing diabetic population—a risk that can be drastically mitigated by the proper application of therapeutic footwear. It is exciting to see how a relatively low-cost intervention can have such a meaningful impact on improved patient outcomes. We look forward to partnering with the Anodyne team to expand the reach of this important preventative product.”
Bobby Kanter, Anodyne’s co-founder and CEO, added, “Anodyne was founded with a vision of being the absolute best. We’ve been relentless in our pursuit to offer at-risk, diabetic patients the most stylish and comfortable footwear available and offer footcare providers the utmost level of service and support in fitting and dispensing these limb-saving devices. The reception from our customers has been overwhelmingly positive, and we are looking forward to accelerating the growth of our brand with HealthEdge’s support.”
Photo courtesy Anodyne
